Atoguanil BA Study

Clinical trial NCT04866602 · COMPLETED

Trial details

NCT number: NCT04866602
Sponsor: Medicines for Malaria Venture
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioavailability

Start date: 2021-11-17
Primary completion: 2022-03-18
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.